While tumor-infiltrating cytotoxic T lymphocytes play a critical role in controlling tumor
development, they are generally impotent in an acidic tumor microenvironment. Systemic …

Theranostic systems by integrating the tumor imaging and tumor therapeutic capabilities into
one platform have attracted numerous attentions from worldwide researchers. Despite the …

A biomimetic nanogel with tumor microenvironment responsive property is developed for the
combinatorial antitumor effects of chemotherapy and immunotherapy. Nanogels are …

Multidrug resistance (MDR) is a major obstacle in the clinical treatment of cancer. Herein, a
facile strategy is reported to construct a versatile DNA nanostructure as a co‐delivery vector …

The progressive development of zeolitic imidazolate frameworks (ZIFs), as a subfamily of
metal‐organic frameworks (MOFs), and their unique features, including tunable pore size …

Highlights•Nanocarriers with the ability to target tumors are being increasingly explored.•
Nanomedicine aid in maintaining a balance between efficacy and toxicity.•Recent advances …

Resistance development to one chemotherapeutic reagent leads frequently to acquired
tolerance to other compounds, limiting the therapeutic options for cancer treatment. Herein …

Precise magnetic hyperthermia/chemo synergistic therapy has attracted great attention as a
promising cancer therapy. However, how to improve the hyperthermia efficiency and …

Recent developments in nanotechnology have brought new approaches to cancer
diagnosis and therapy. While enhanced permeability and retention effect promotes nano …

Cytosolic delivery is the major challenge that limits the clinical translation of siRNA-based
therapeutics. Although thousands of polymers have been developed for siRNA delivery, the …